191 related articles for article (PubMed ID: 22228288)
21. Heparin-coated bypass circuits in cardiopulmonary bypass: improved biocompatibility or not.
Levy M; Hartman AR
Int J Cardiol; 1996 Apr; 53 Suppl():S81-7. PubMed ID: 8793597
[TBL] [Abstract][Full Text] [Related]
22. Biocompatibility of heparin-coated extracorporeal bypass circuits: new heparin bonded bioline system.
Tayama E; Hayashida N; Akasu K; Kosuga T; Fukunaga S; Akashi H; Kawara T; Aoyagi S
Artif Organs; 2000 Aug; 24(8):618-23. PubMed ID: 10971248
[TBL] [Abstract][Full Text] [Related]
23. Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome.
Svenmarker S; Häggmark S; Jansson E; Lindholm R; Appelblad M; Sandström E; Aberg T
Scand Cardiovasc J; 2002 Aug; 36(4):241-6. PubMed ID: 12201973
[TBL] [Abstract][Full Text] [Related]
24. Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass.
Shimamoto A; Kanemitsu S; Fujinaga K; Takao M; Onoda K; Shimono T; Tanaka K; Shimpo H; Yada I
Ann Thorac Surg; 2000 Jan; 69(1):115-20. PubMed ID: 10654498
[TBL] [Abstract][Full Text] [Related]
25. Clinical effects of the heparin coated surface in cardiopulmonary bypass.
Svenmarker S; Sandström E; Karlsson T; Jansson E; Häggmark S; Lindholm R; Appelblad M; Aberg T
Eur J Cardiothorac Surg; 1997 May; 11(5):957-64. PubMed ID: 9196315
[TBL] [Abstract][Full Text] [Related]
26. 'High dose' aprotinin and heparin-coated circuits: clinical efficacy and inflammatory response.
Parolari A; Alamanni F; Gherli T; Salis S; Spirito R; Foieni F; Rossi F; Bertera A; Oddono P; Biglioli P
Cardiovasc Surg; 1999 Jan; 7(1):117-27. PubMed ID: 10073771
[TBL] [Abstract][Full Text] [Related]
27. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
[TBL] [Abstract][Full Text] [Related]
28. Is there evidence that fresh frozen plasma is superior to antithrombin administration to treat heparin resistance in cardiac surgery?
Beattie GW; Jeffrey RR
Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):117-20. PubMed ID: 24014620
[TBL] [Abstract][Full Text] [Related]
29. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C
Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
[TBL] [Abstract][Full Text] [Related]
30. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
[TBL] [Abstract][Full Text] [Related]
31. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
[TBL] [Abstract][Full Text] [Related]
32. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
[TBL] [Abstract][Full Text] [Related]
33. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits.
Tanaka H; Oshiyama T; Narisawa T; Mori T; Masuda M; Kishi D; Kitou T; Miyazima S
J Artif Organs; 2003; 6(4):245-52. PubMed ID: 14691666
[TBL] [Abstract][Full Text] [Related]
34. Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes.
Mangoush O; Purkayastha S; Haj-Yahia S; Kinross J; Hayward M; Bartolozzi F; Darzi A; Athanasiou T
Eur J Cardiothorac Surg; 2007 Jun; 31(6):1058-69. PubMed ID: 17306555
[TBL] [Abstract][Full Text] [Related]
35. Impact of heparin bonding on pediatric cardiopulmonary bypass: a prospective randomized study.
Grossi EA; Kallenbach K; Chau S; Derivaux CC; Aguinaga MG; Steinberg BM; Kim D; Iyer S; Tayyarah M; Artman M; Galloway AC; Colvin SB
Ann Thorac Surg; 2000 Jul; 70(1):191-6. PubMed ID: 10921707
[TBL] [Abstract][Full Text] [Related]
36. Transfusion after coronary artery bypass surgery: the impact of heparin-bonded circuits.
Mahoney CB; Lemole GM
Eur J Cardiothorac Surg; 1999 Aug; 16(2):206-10. PubMed ID: 10485422
[TBL] [Abstract][Full Text] [Related]
37. Con: heparin-bonded cardiopulmonary bypass circuits do not represent a desirable and cost-effective advance in cardiopulmonary bypass technology.
Woolf RL; Mythen MG
J Cardiothorac Vasc Anesth; 1998 Dec; 12(6):710-2. PubMed ID: 9854674
[No Abstract] [Full Text] [Related]
38. In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass.
Ask A; Holt D; Smith L
J Extra Corpor Technol; 2006 Mar; 38(1):27-32. PubMed ID: 16637520
[TBL] [Abstract][Full Text] [Related]
39. Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population.
Videm V; Mollnes TE; Fosse E; Mohr B; Bergh K; Hagve TA; Aasen AO; Svennevig JL
J Thorac Cardiovasc Surg; 1999 Apr; 117(4):794-802. PubMed ID: 10096976
[TBL] [Abstract][Full Text] [Related]
40. Low heparinization with heparin-bonded bypass circuits: is it a safe strategy?
Bannan S; Danby A; Cowan D; Ashraf S; Martin PG
Ann Thorac Surg; 1997 Mar; 63(3):663-8. PubMed ID: 9066381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
